The Australia & New Zealand diabetes devices market is booming, projected to reach \$1.42 billion by 2033, driven by rising diabetes prevalence and adoption of advanced technologies like CGM and insulin pumps. Learn about market trends, key players (Roche, Medtronic, Abbott), and future growth opportunities.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.